Saturday, December 28, 2013

Karex - Strengthening Its Lead (RHB)

Karex Bhd -
Target Price: MYR4.43
Price: MYR3.86
Strengthening Its Lead

After  our  recent  meeting  with  management,  we  raise  our  FY14F-15F earnings  forecasts  by  12-26%  as  we  become  more  upbeat  on  the company’s outlook. We continue to like Karex for its lead in the condom manufacturing  industry  and  strong  earnings  growth  spurred  by capacity  expansion.  Maintain  BUY, with  our FV  lifted  to  MYR4.43  (from MYR3.51).

Expansion plans on track. Karex’s expansion plans are well on track to achieve  its  target  to  add  1bn  pieces  annually  to  6bn  pieces  by  2015. According  to  management,  utilisation  rates  currently  stand  at  about >80%,  with  lead  time  of  4-5  months,  even  after  four  new  lines  were installed  in  2QFY14.  We  gather  that  the  company  has  steady  orders from  existing  and  new  customers  from  both  the  tender  and  commercial markets  to  fill  up  its  new  capacity.  Moving  forward,  Karex  expects  to normalise its lead time to 1-2 months with average utilisation rates of 70-75%, which are the optimal levels for condom manufacturers.

Minimal  impact  from  electricity  hike.  On  2  Dec,  the  Malaysian Government announced that electricity tariffs will be raised by 16.85% to 38.5  sen/kilowatt  hour  (kWh)  from  1  Jan  2014.  Management  believes that  the impact  will  be  limited as  electricity  costs  only  make  up  5-6% of the company’s  total  production  cost  and  can  easily  be  mitigated  by easing raw material prices and the appreciation of the USD vs MYR.

Revising  estimates  higher.  In  view  of  the company’s positive outlook, we raise our FY14F-15F earnings estimates by 12-26%, as our previous assumptions  were  too  conservative.  We  revise  our  latex  price assumption to MYR5.50/kg (from MYR6.00 per kg) and lift our utilisation rate  assumption  to  67-70%  (from  65-67%). We  are now  forecasting  net profits of MYR44.0m-59.8m for FY14F-15F respectively.

Maintain  BUY.  Consequently,  we  bump  up  our  FV  to  MYR4.43  (from MYR3.51), based on an existing 20x P/E on FY15 earnings, which  is in line  with  our  target  valuation  for  Hartalega  (HART  MK,  BUY,  FV: MYR7.95).  We  continue  to  like  Karex’s:  i)  leadership  in  the  condom manufacturing  industry,  ii)  strong  earnings  growth  spurred  by  capacity expansion,  and  iii)  stable  operating  environment  amid  stabilising  raw material prices and the appreciation of the USD against MYR.

Source/Extract/Excerpts/来源/转贴/摘录: RHB-Research,
Publish date: 20/12/13

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)

乔治·索罗斯(George Soros)



高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo

There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock